High hyperdiploidy among adolescents and adults with acute lymphoblastic leukaemia (ALL): cytogenetic features, clinical characteristics and outcome. Chilton L et al Leukemia 2013

Targeting signaling pathways in acute lymphoblastic leukemia: new insights. Harrison CJ et al Hematology Am Soc Hematol Educ Program 2013

UKALLXII/ECOG2993: addition of imatinib to a standard treatment regimen enhances long-term outcomes in Philadelphia positive acute lymphoblastic leukemia. Fielding AK et al Blood 2013

Acute lymphoblastic leukemia in children with Down syndrome: a retrospective analysis from the Ponte di Legno study group. Buitenkamp TD et al Blood 2013

An international study of intrachromosomal amplification of chromosome 21 (iAMP21): cytogenetic characterization and outcome. Harrison CJ et al Leukemia 2013

Cytogenetics and outcome of infants with acute lymphoblastic leukemia and absence of MLL rearrangements. De Lorenzo P et al Leukemia 2013

Unravelling the prognostic effect of IKZF1 deletions and IGH@-CRLF2 in adult acute lymphoblastic leukaemia. O'Reilly J et al Pathology 2013 45(6):609-612

Pediatric acute myeloid leukemia with t(8;16)(p11;p13): a distinct clinical and biological entity, a collaborative study by the International-Berlin-Frankfurt-Munster AML-study group. Coenen et al Blood 2013 122(15):2704-2713

Independent prognostic value of BCR-ABL1-like signature and IKZF1 deletion, but not high CRLF2 expression, in children with B-cell precursor ALL. van der Veer et al Blood 2013 122(15):2622-2629

Risk-Directed Treatment Intensification Significantly Reduces the Risk of Relapse Among Children and Adolescents With Acute Lymphoblastic Leukemia and Intrachromosomal Amplification of Chromosome 21: A Comparison of the MRC ALL97/99 and UKALL2003 Trials. Moorman AV et al J Clin Oncol 2013 31(27): 3389-3396

Chromosomal translocations involving the IGH@ locus in B-cell precursor acute lymphoblastic leukemia: 29 new cases and a review of the literature. Chapiro et al Cancer Genetics 2013 206(5):162-173

Long term follow-up of ETV6-RUNX1 ALL reveals that NCI risk, rather than secondary genetic abnormalities, is the key risk factor. Enshaei A et al Leukemia 2013 27(11): 2256-2259

Genes commonly deleted in childhood B-cell precursor acute lymphoblastic leukemia: association with cytogenetics and clinical features. Schwab CJ et al Haematologica 2013 98(7):1081-8

The clinical characteristics, therapy and outcome of 85 adults with acute lymphoblastic leukemia and t(4;11)(q21;q23)/MLL-AFF1 prospectively treated on UKALLXII/ECOG2993. Marks DI et al Haematologica 2013 98(6):945-952

Abnormalities of the der(12)t(12;21) in ETV6-RUNX1 acute lymphoblastic leukemia. Al-Shehhi H et al Genes Chromosomes Cancer 2013 52(2): 202-213

Loss of chromosomes is the primary event in near-haploid and low hypodiploid acute lymphoblastic leukemia. Safavi S et al Leukemia 2013 27(1):248-250

Treating childhood acute lymphoblastic leukemia in Malawi. Chagaluka G et al Haematologica 2013 98(1):1-3